Added to YB: 2025-12-10
Pitch date: 2025-12-06
EW [bullish]
Edwards Lifesciences Corporation
-3.41%
current return
Author Info
No bio for this author
Company Info
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Market Cap
$50.0B
Pitch Price
$86.01
Price Target
100.00 (+20%)
Dividend
N/A
EV/EBITDA
25.79
P/E
37.70
EV/Sales
7.97
Sector
Health Care Equipment and Supplies
Category
special_situation
Institutional Trade Analysis: Decoding the Bullish Risk Reversal in Edwards Lifesciences
EW: Whale trade reveals institutional conviction: long $92.50 calls/short $82.50 puts (Mar 2026) for ~$0.40 net. Betting on Q1 2026 catalysts: JPM conference, Q4 earnings, SAPIEN M3 FDA approval. TMTT growing 57% YoY. Trade exploits vol skew, targets $100 on regulatory approval.
Read full article (4 min)